UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036175 |
|---|---|
| Receipt number | R000041212 |
| Scientific Title | Research to narrow down patients with liver cirrhosis hidden from health checkup examinees |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2021/09/14 01:27:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Research to narrow down patients with liver cirrhosis hidden from health checkup examinees
Acronym
Research to narrow down patients with liver cirrhosis hidden from health checkup examinees
Scientific Title
Research to narrow down patients with liver cirrhosis hidden from health checkup examinees
Scientific Title:Acronym
Research to narrow down patients with liver cirrhosis hidden from health checkup examinees
Region
| Japan |
Condition
Condition
Liver cirrhosis
Classification by specialty
| Medicine in general | Hepato-biliary-pancreatic medicine | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
narrowing down liver cirrhosis from medical checkup examinee using measurement of WFA+-M2BP
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Diagnostic accuracy of liver cirrhosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Medical examination examinee of age 20 years or older
Patients who obtained written informed consent
Key exclusion criteria
Patients with HCV, HBV, AIH and PBC
Target sample size
2000
Research contact person
Name of lead principal investigator
| 1st name | Masayuki |
| Middle name | |
| Last name | Kurosaki |
Organization
Musashino Red Cross Hospital
Division name
Department of Gastroenterology and Hepatology
Zip code
180-8610
Address
1-26-1, Kyonancho, Musashinoshi, Tokyo
TEL
+81-422-32-3111
kurosaki@musashino.jrc.or.jp
Public contact
Name of contact person
| 1st name | Nobuharu |
| Middle name | |
| Last name | Tamaki |
Organization
Musashino Red Cross Hospital
Division name
Department of Gastroenterology and Hepatology
Zip code
180-8610
Address
1-26-1, Kyonancho, Musashinoshi, Tokyo
TEL
+81-422-32-3111
Homepage URL
tamaki@musashino.jrc.or.jp
Sponsor or person
Institute
Musashino Red Cross Hospital
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Musashino Red Cross Hospital clinical research ethics committee
Address
1-26-1, Kyonancho, Musashinoshi, Tokyo
Tel
+81-422-32-3111
shomu2@musashino.jrc.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
2021
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2019 | Year | 01 | Month | 30 | Day |
Date of IRB
| 2019 | Year | 01 | Month | 30 | Day |
Anticipated trial start date
| 2019 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2021 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
None
Management information
Registered date
| 2019 | Year | 03 | Month | 12 | Day |
Last modified on
| 2021 | Year | 09 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041212
